In this free webinar, learn about the US FDA's recommended patient-reported outcomes (PROs) strategy. Attendees will gain insights into what domains should be measured in oncology trials to enable full realization of a treatment's value and facilitate comparison across studies. The featured speaker will discuss the new concept of a modular approach – selecting only the relevant items from an existing instrument – for clinical trials. Attendees will gain an understanding on how PROs can be captured outside clinical settings.
TORONTO, April 3, 2023 /PRNewswire-PRWeb/ -- The new FDA Patient Focused Drug Development (PFDD) Guidance Series and the Core Patient-Reported Outcomes Measures (PROMs) in Cancer Clinical Trials Guidance demonstrates the industry's commitment to optimizing clinical trial design, presenting the opportunity to minimize participant and site burden. Traditionally, oncology trials have been solely site-based, with lengthy, complex, and burdensome visits. They have also lacked a standard set of PRO domains and can have high levels of missing data.
Employing flexible approaches to data capture and leveraging technology can help. But, we must ensure they are fit-for-purpose and trial appropriate.
In this webcast, Flo Mowlem, Senior Director, eCOA Science & Solutions at Medable will share insights on how electronic solutions, with a focus on patient-reported outcome (ePROs) can reduce burden on participants and sites to maximize the chance of success in oncology clinical trials.
You'll discover: An outline of the recommended PRO strategy from the FDA; Knowledge of what domains should be measured in oncology trials to enable full realization of a treatment's value and facilitate comparison across studies; Discussion around the new concept of a modular approach – selecting only the relevant items from an existing instrument – for clinical trials; And an understanding on how PROs can be captured outside clinical settings.
Join Flo Mowlem, PhD, Senior Director, eCOA Science & Solutions, Medable, for the live webinar on Monday, April 24, 2023, at 12pm EDT (9am PDT).
For more information, or to register for this event, visit Leverage Novel Options in Oncology Clinical Trial Design to Reduce Burden For Patients and Sites.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article